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ABSTRACT
A study was performed to develop a Monte Carlo method of modeling neutron shielding
of proton therapy facilities in a complex, realistic environment. The bulk neutron
shielding of the Northeast Proton Therapy Center (Massachusetts General Hospital,
Boston, MA) was used as the basis of the design work. A geometrical model of the
facility was simulated using the LAHET Code System, a set of Monte Carlo codes
developed at Los Alamos National Laboratory. Additional software tools for reading and
analyzing the simulation data that the model provides have been developed and tested. In
order to verify the computer simulations, neutron detection and data acquisition systems
have been assembled, modified, and thoroughly tested in order to monitor the neutron
dose equivalent during proton beam operation at several locations on a continuous basis.
Preliminary tests show that the geometry and physics models proposed in this work are
valid.
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SECTION 1 - INTRODUCTION
Proton therapy is a radiotherapy modality that uses beams of high-energy protons
to deliver a tightly-constrained amount of energy to a specified target volume in order to
selectively destroy tumor cells with minimal deleterious effect on surrounding healthy
tissue. In the course of producing and delivering high-energy proton beams, a significant
radiological hazard is introduced by neutrons that are generated as a result of protons
undergoing nuclear interactions with materials in the beam path. These neutrons are the
dominant secondary radiation field in proton therapy and shielding must be designed to
protect the workers in close proximity to the therapy equipment and the general public.
Larson et al.28 designed the radiation shielding for the Northeast Proton Therapy
Center (NPTC), located on the Massachusetts General Hospital (MGH) campus in
Boston, using a variety of analytical techniques. The shielding design is a complex and
difficult engineering task that is not easily modeled with analytical methods. In most
cases, previous shielding calculations have followed a simplified approach in which the
energy and angular distributions of secondary neutrons produced by proton beam
interactions are calculated and then transported through a concrete shield wall. The
energy and angular distributions of the attenuated neutrons are then calculated at several
depths in the concrete, and the neutron dose equivalent is calculated from these
distributions. ' 29 '30,50 For a single-source situation with a simple flat or spherical wall
surrounding it, these approximations are sufficient. However, these methods can at best
approximately model the complexity introduced by multiple sources interacting with
multiple neutron shielding barriers, as is the case in a multi-purpose proton therapy
facility capable of producing and delivering proton beams with a wide range of energies
to a variety of locations and targets.
It is the goal of this work to develop more accurate methods for predicting
shielding performance. Specifically, an existing Monte Carlo code is being modified and
supplemented with additional computer codes that allow the simulation of neutron
shielding in a complex, realistic geometry. Towards this end, a computer model of the
Northeast Proton Therapy Center's bulk neutron shielding geometry has been created. In
addition, neutron dosimetry instrumentation has been developed for confirmatory
measurements. These instruments will provide experimental verification of the shielding
performance at NPTC once the beam delivery systems and beamline instrumentation are
fully operational.
The simulation of the NPTC shielding and the software tools developed in this
work are expected to yield great potential benefits for future work in proton therapy, as
these calculational tools can be applied to the optimization of neutron shielding designs
for future facilities. This may allow future designers to use less shielding material and as
a result reduce the cost of the construction of new facilities. Any reduction in the size of
the shielding walls will also free up floor space, which is especially important in urban





Figure 1.1. Layout of the treatment floor of the Northeast Proton Therapy Center.
Figure 1.1 illustrates the layout of the NPTC treatment floor.7 The focus of the computer
model is the 3-dimensional region within the dashed box, which contains all of the
neutron shielding barriers (the dotted regions) and the beam delivery components, i.e., the
accelerator, energy degrader, bending/focusing magnets, and patient positioning system.
This work is organized as follows:
* Section 2 provides background information on how the neutron fields are produced by
the proton beam interactions with materials in the beam transport components and
with the patient.
* Section 3 describes pertinent characteristics of the Northeast Proton Therapy Center,
the general specifications for the neutron shielding in terms of the neutron sources,
regulatory limits on dose equivalent, and factors that influence the choice of shielding
material.
* Section 4 provides information on Monte Carlo techniques for radiation transport
simulations and on the Los Alamos High Energy Transport Code (LAHET), the
Monte Carlo code that was chosen for the NPTC simulations.
* Section 5 covers the Monte Carlo calculation methods for the simulation of NPTC,
including a detailed geometrical model of the neutron shielding barriers, the
determination of the neutron source terms, the characterization of the materials, the
development of new codes to process the massive amount of data generated in the
course of the LAHET calculations, and how best to interpret the simulation results.
* Section 6 describes a measurement system for experimentally verifying the LAHET
predictions of neutron dose equivalent.
* Section 7 presents the conclusions of this work and illustrates the potential
applications this study may have in the design of future proton therapy facilities.
SECTION 2 - BACKGROUND
In predicting the radiological hazards presented by the clinical operation of a
proton accelerator, the means by which neutrons are produced must be taken into account.
The neutron production reactions that protons undergo in various target materials is
dependent both on the incident proton energy and/or the characteristics of the target nuclei.
Different proton-induced nuclear reactions result in widely different resulting neutron
radiation fields, and accurate neutron dose equivalent determination requires detailed
information on the characteristics of these fields. This necessitates the use of models that
adequately predict the radiation fields expected during normal clinical operation of the
accelerator.
2.1 Proton Beams
For the last 75 years, radiation has been used to non-invasively treat malignant
tumors in living tissue. First proposed by Wilson61 in 1946 and implemented in 1957,49
high energy protons have augmented the armamentarium of radiation 'modalities,' initially
constrained to gamma rays, x rays, and electrons, used to selectively irradiate cancerous
tissue.38 The primary motivating factor for the clinical use of these widely differing
modalities has been to improve control over the deposition of therapeutic dose.29 Sources
of electromagnetic radiation, such as x rays or gamma rays, deposit energy over an
extended region, i.e., proximal and distal to the target volume, even with the most precise
restraint on the beams' spread in the lateral directions. Electrons are easily scattered and
their directionality is poorly constrained. High-energy proton beams, on the other hand,
have very different physical characteristics. Protons of a given energy penetrate a finite
distance into the patient, and then come to rest. The range of protons in water is described
in Equation 2.1, which corresponds to physical data for the proton energy range from 100
to 250 MeV 6
R i = (2.63xl 0-3)x(Ei) 1.74 ( m 2 ) (2.1)
where R i is the range of the incident proton and Ei is its associated energy in MeV.
Equation 2.1 is known as the "range-energy relation." This pattern energy deposition
characteristic of proton beams is known as a Bragg Curve, and an example is shown in
Figure 2.1.
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Figure 2.1. Dose-depth plot for 170 MeV protons in water. 65
Point A in Figure 2.1 is in the region of the Bragg Curve where the incident proton is still
fairly energetic and the rate of energy loss is small. The rate of energy deposition
increases as the proton loses energy, reaching a maximum at the "Bragg peak."(Point B)
After this localized maximum, the proton energy loss rate falls off rapidly (Point C).
During the course of the proton's penetration, its greatest energy deposition rate, and
consequently its dose rate, is near the Bragg peak. Thus, when protons are directed at a
tumor they deliver virtually no dose beyond it, and less dose than x-rays or electrons
proximal to it. This can lead to very favorable dose distributions which may allow more
dose to be delivered to the tumor while sparing the surrounding healthy tissues. 52 Many of
the tumors that require radiotherapy are located near critical structures (organs that are
particularly radiosensitive, such as the central nervous system or the lungs) the use of
heavy charged particles such as protons as a treatment modality has proven advantages. 29,52
In order to treat locations deep within human tissue, a means of producing protons
of sufficient energy must be available. Starting in 1962, the Harvard Cyclotron
Laboratory (Cambridge) proton synchrocyclotron has been a valuable resource for this
proton technology, providing proton beams for Massachusetts General Hospital that have
been used to treat over 7000 patients. Its original design energy was about 140 MeV.3 8 In
order to be able to deliver a dose to any region of the human body, a mean proton beam
energy of around 235 MeV is required. A proton beam of 235 MeV gives a range of about
34 cm in water, which allows the irradiation of even a very thick patient from any angle in
a plane perpendicular to the patient's longitudinal axis. Such a beam is available at the
Loma Linda University Medical Center (San Bernadino, CA), and will soon be available
for clinical use at the Northeast Proton Therapy Center (MGH - Boston, MA).38
2.2 Neutron Sources
The principal concern in shielding medical proton accelerators is to attenuate the
neutron radiation field produced by the (p,xn) reactions in the beam transport components,
the accelerator structure, the energy selection system, and the patient to a level within
regulatory limits." The estimation of shielding for proton accelerators requires a detailed
understanding of the production of particles by the interaction of the primary protons, their
transport through the shield and the determination of the energy spectrum of the radiations
that escape from the shield. In the energy ranges used clinically at NPTC (70-235 MeV),
these calculations are made even more difficult by the rapid changes in hadron cross-
sections with energy, and the large differences in neutron yields resulting from these
interactions. For example, 70 MeV protons incident on a copper target produce on
average 5.5x10-2 neutrons per incident proton, while 200 MeV protons produce on average
1 neutron per incident proton, almost a twenty-fold difference in neutron yield. 54
The neutrons in the treatment rooms result primarily from production within the
beam scattering system in the nozzle, the defining aperture, and the patient. The intensity
of the neutron field is dependent on the energy and current of the delivered proton beam.
The neutron radiation field around the proton beam transport system is primarily due to
proton interactions with the beamline components, such as the bending and focusing
magnets. The neutron radiation field associated with the energy selection system is due to
the proton-induced nonelastic nuclear reactions in the variable thickness graphite energy
degrader wheel. A diagram locating these components is provided in Section 3.2.1.
The proton source intensity to be utilized must be specified before any shield
design is attempted. In many cases this specification will be straightforward - such as, for
example, where a single proton beam utilizes only one beam stop. When multiple beam
operation is planned, as is the case at the Northeast Proton Therapy Center, the
specification of the source term becomes much more difficult to estimate. The intensity of
the neutron beam may vary from treatment to treatment, and an upper limit to the proton
beam intensity may be necessary to insure that the dose to the patient can be safely
controlled. MGH took these considerations into account when they specified a limit on
the maximum proton current the accelerator could produce to 300 nA, approximately one-
fifth of the accelerator's maximum output.
2.2.1 Particle Yields from Proton-Nucleus Interactions
For all target materials at primary proton energies E between 50 MeV and 500
MeV, the neutron yield is roughly proportional to the total proton energy squared, E 2
According to Puppi and Dalaporta47:
N E2
S-= - (m0c) 2  (2.1)P E2 - (MC2)2
N
Where - is the neutron yield per incident proton ratio, E is the proton total energy, andP
moc 2 is the proton rest mass.
For detailed calculations for radiation protection, more than just the number of
neutrons produced is required: in particular, the energy and angular distribution of the
neutrons must be known. The quantities are needed because the quality factor for neutron
dose equivalent determination, Q, is a function of neutron energy, and the angular
distribution is needed to examine the effects of multiple barriers in a 3-dimensional
system. Two nuclear processes that are of particular importance in determining the yield
of particles following proton-nucleus interactions: nuclear evaporation and intranuclear
cascade.
2.2.2 Nuclear Evaporation
Neutron evaporation is summarized by a two-step model, consisting of the
formation of a compound nucleus followed by particle emission and de-excitation. This
compound nucleus is in an excited state with a number of allowed decay channels; the
preferred decay channel is most energetically favorable, i.e., the entrance channel. As the
energy of the incident particle increases, the number of levels available in the incident
channel becomes very large; there are no longer discrete levels in the quasi-stationary
states of the compound nucleus but rather a complete overlapping of levels inside the
nucleus. Under these conditions the emission of particles is best described by an
evaporation process analogous to the evaporation of a molecule from the surface of a
liquid. 7 The energy distribution of emitted neutrons can be described by a Maxwellian
distribution of the form:
-E
n(E)dE = cEe 5 (2.2)
where n(E) is the number of neutrons emitted at energy E (in MeV), dE is the energy
interval, r is a so-called nuclear temperature and has the dimensions of energy in MeV,
and c is a constant specific to the system." Similar equations describe the emission of
protons, deuterons, and heavier charged particles, but at clinically relevant proton energies
these do not influence shielding considerations because their ranges are at most a few
centimeters. The evaporated particles are emitted isotropically, and the energy distribution
of the evaporated neutrons extends up to about 8 MeV.5 4
2.2.3 Intranuclear Cascade
At higher proton energies (above about 50 MeV) the development of an
intranuclear cascade becomes important. The intranuclear cascade develops through an
interaction of individual nucleons inside the nucleus; the probability of these interactions
is determined by the free nucleon cross-sections and by the Pauli exclusion principle. 4 12' 34
These neutrons are emitted preferentially in the forward direction (with respect to the
incident proton direction), and by definition may have energies ranging from 8 MeV up to
about the incident proton energy.54
The number of neutrons per unit energy per solid angle per interaction (cascade or
evaporation) of a proton of kinetic energy Eo MeV can be represented by:
15 E Ei  1 1
n(E) = exp E ai +- exp aj (2.3)
E i=0 4r 25 j=0
where the first term refers to the yield from the intranuclear cascade and the second term
refers to the yield from evaporation. The coefficients ai and a are given so that the energy
distributions for both evaporation and cascade neutrons and for each angular region may
be calculated. 57
2.3 Neutron Radiation Fields
The prompt radiation of particle accelerators exists only while they are in
operation. As described above, this radiation field may result as a natural consequence of
the acceleration process and the utilization of the accelerated beam. The most complex
radiation environments around particle accelerators will generally arise at locations where
the shielding is 'thin,' i.e., insufficient to fully attenuate the charged particles produced by
primary proton-induced nuclear reactions. This situation dominates inside the main
shielding barriers. Before interacting, the accelerated beam is basically monoenergetic and
of one particle type. Passage through the accelerator structure, experimental equipment or
thin shielding will lead to the partial development of electromagnetic and hadronic
cascades and the production of many types of particles distributed over a wide range of
energies. Outside the main shielding barriers, the situation is simplified. Despite the large
variety of high energy particle accelerators, both with respect to beam characteristics and
utilization, their external radiation environments outside the shields are often quite similar,
and are usually dominated by neutrons ranging in energy from thermal up to about the
proton energy (235 MeV for NPTC). 16 '17
2.4 Dosimetry
One of the most important aspects of radiation protection dosimetry at particle
accelerators is the interpretation of measurements in terms of the particular dose
equivalent quantities required by regulation and statute. The quantity 'dose equivalent'
was first formally defined as recently as 1968,24 although its origins go back a further
twenty years to the application of relative biological effectiveness (RBE) dose to
radiological protection.39 Thomas has reviewed the long-standing discussion concerning
the definition of both the quantity and its units.56 For sources of radiation exposure
external to the body, the dose equivalent H is defined by the equation:
H = Q(L (L dLo (2.4)
0dL
dD(LOO )Where L,o is the unrestricted linear collision stopping power in water, d is the
dL0
absorbed dose in the stopping power increment from Lo to (Loo + dLo ), Q(Lo) is the
quality factor as a function of stopping power as defined by ICRU and ICRP, 20, 24 and the
integral of equation 2.2 is evaluated over the entire Loo spectrum.
The primary limits for radiation exposure recommended by the ICRP are expressed
in terms of the dose equivalent to various tissues Ht, the whole body dose equivalent Hwb,
and the effective dose equivalent HE. For external radiation exposure, secondary limits are
expressed in terms of the shallow and deep dose equivalent indexes HI,s and HI,d. 2 Since,
in general, neither the primary nor the secondary limits may be measured directly,






The most widely used operational dose equivalent quantity for neutrons is the dose
equivalent Hr, determined from the measured neutron fluence Dm, and a fluence-to-dose-
equivalent conversion coefficient h. The coefficient h stands for h(E), expressed in units
of dose equivalent per unit fluence. Use of these conversion coefficients requires that the
irradiated volume be large enough that the mean chord length is greater than the mean free
path of the most penetrating secondary charged particles that are generated by neutron
interactions in the target volume. 65 The dose equivalent for monoenergetic neutrons is
then
HC = h m (2.5)
For polyenergetic neutrons, the equation becomes
Hc(E) = h(E)<m(E) (2.6)
The fluence-to-dose conversion coefficients from the United States Nuclear Regulatory
Commission are given below in Table 2.1. 5' These conversion coefficients are appropriate
when the mean free paths of the secondary neutrons originally engendered by the proton
beam are much longer than those of the tertiary charged particles produced by neutron
interactions in the target, and when the target is sufficiently large compared to the mean
free paths of these tertiary charged particles.65
Table 2.1. Fluence per unit dose equivalent (h(E)) for neutrons.s8
Neutron Energy, E 10 CFR 20 Fluence-to-Dose Equivalent
Conversion Coefficient, h(E)
(MeV) (mrem/h)/(n/cm 2*sec)
2.5x10 -8  1.0204x10 -6
1.0x10 -7  1.0204x10-6
1.0x10-6  1.2346x10-6
1.0x10 5  1.2346x10-6
1.0x10 -4  1.1905x10 -6
1.0x10 -3  1.0204x10 -6
















For the purposes of radiation protection, it is necessary to devise a "phantom" to
mimic the properties of human tissue in a radiation field. Using a 15-cm radius sphere
composed of a tissue equivalent material has the following advantages:
(1) It is relatively uncomplicated.
(2) The widely accepted specifications of its composition (tissue) allow ready
comparison with calculations and measurements at other laboratories.
(3) It has an isotropic response to radiation.
(4) It is a reasonable phantom for calibration purposes (e.g. for personal dosimeters
worn on the human abdomen).
While such a sphere can never be used to determine organ dose equivalents or the
effective dose equivalent, it is very effective for purposes of radiation protection, and can
be used to characterize the potential irradiation of an individual in terms of a single whole-
body dose equivalent quantity.
In the simulations that are going to be performed for NPTC, a 15 cm radius sphere,
composed of A-150 plastic, has been chosen. A 15-cm radius sphere also has the
advantages of satisfying the size requirements necessary for use of the fluence-to-dose
equivalent conversion coefficients described in Section 2.3. A-150 plastic has a mass
composition of 77.55% carbon, 10.13% hydrogen, 5.23% oxygen, 3.51% nitrogen, 1.84%
calcium, and 1.74% fluorine, which has been found to approximate the neutronic
properties of human tissue very accurately.36 The compositions used in the computer
simulation are summarized in the Appendix.
2.6 Summary
In this section the basic mechanisms of neutron production from the operation of a
proton accelerator were explained. The complexity of the neutron fields and the resulting
effects on the neutron dose equivalent characteristics were also examined, and a simple
phantom was chosen to realistically simulate exposures to workers and member of the
general public.
SECTION 3 - SHIELDING SPECIFICATIONS
3.1 Shielding Design Goals
The goal of proton therapy accelerator shielding designs is to attenuate the
radiation produced in the accelerator and its associated equipment, of which neutrons are
the dominant shielding concern, in order to protect patients, staff, and members of the
general public. An efficient shielding design should minimize the cost without
compromising the utility of the particle accelerator for its designed purposes. This is
achieved in three stages:
(1) Determination of the neutron source terms (See 2.1, 3.2.2)
(2) Specification of the acceptable dose equivalent levels outside the shielding
(See 3.2.3)
(3) Design of a shield with adequate attenuation to achieve the acceptable dose
equivalent limits, with sufficient flexibility to permit efficient accelerator
operation, with readily available materials and at optimum cost.
In the case of the Northeast Proton Therapy Center, stages 1 and 3 are complicated by the
complex arrangement of proton beam transport equipment. At any point in the beam
transport, stray protons can interact with the bending and focussing magnets, which may
result in neutron production. Neutron production will also arise from protons interacting
with the accelerator structure itself, the graphite energy degrader wheel of the energy
selection system, and the various beam delivery systems. The energy of the proton beam,
direction of incidence, and the beam stop locations and materials also influence the
neutron source term. The arrangement and design of the some of the shielding barriers is
complicated by the space and utility restraints, e.g., maze geometries to allow access to
the cyclotron vault and treatment rooms.
3.2.1 The MGH NPTC Cyclotron and Beam Delivery Components
The NPTC cyclotron was designed by Ion Beams Applications (IBA) for the
production of a proton beam suitable for clinical use.26 The equipment setup is shown in
Figure 3.1, showing the relative locations of the cyclotron, the energy selection system,
the beam line, and the treatment rooms. Its major characteristics are:
(1) Energy - The NPTC cyclotron is a zero-gradient synchrotron, injected from a
radiofrequency quadrupole at 2 MeV, fixed energy of 235 MeV. Nearly
continuous energy selection is available by degrading the proton energy in a
graphite absorber wheel with variable thicknesses. Monochromaticity of
proton energy is provided by analyzing magnets and slits. This allows for a
range of proton energies from 70 to 235 MeV.
(2) Current - Clinical currents usually run in the region of 10 nA, corresponding
to approximately 6x1010 protons/s. The maximum beam current is 1.5 mA,
but has been hardware limited to 300 nA for patient safety. This current is
approximately equal to 2x1012 protons/s.
(3) Beam Transport and Directionality - The beam can be directed into either
of two gantry treatment rooms, an experimental bay, an eye-treatment station,
or a large-field treatment platform. The beam can only be directed to one of
these stations at a time. The gantries rotate through 360 degrees and allow the
beam to be pointed in any direction in a vertical plane.
Figure 3.1. MGH NPTC proton therapy equipment.26
3.2.2 Determination of the Source Terms
Proton interactions with materials in the beamline can occur at any time during
operation. Neutron production may arise from any of these interactions. The materials in
the beamline that were intended to stop either all or some fraction of the proton beam at
some time are termed 'beam stops,' e.g., a copper Faraday cup for measuring proton
beam current or the patient being treated. The beam loss scenarios described in the
following sections (3.2.2.1 and 3.2.2.2) were estimated by the NPTC Radiation Safety
Committee and were used by Larson et al. for their shielding design work.28,37
3.2.2.1 Operational Beam Loss
There are many locations in the accelerator, proton energy selection system, and
beam delivery equipment where protons can interact and produce neutrons. The
shielding design by Larson et al.37 assumes the three sets of copper beam stops
recommended by the NPTC Safety Committee. 28 There will also be a degree of beam
loss within the energy degrader wheel, including energy loss through coulombic
interactions and multiple coulomb scattering and current loss through (p,xn) reactions
(see Section 2.2). However, the neutron source terms from the copper beamstops will
tend to dominate as neutron production in high-Z materials (such as copper) is greater
than that in low-Z materials (such as the carbon in the graphite beam stop). Directing the
proton beam into beam stops is sometimes necessary for diagnostic purposes. Following
are the design specifications from the NPTC Radiation Safety Committee, which were
formulated to prevent accelerator personnel from exceeding the capabilities of the neutron
shielding:28
(1) The first beam stop is located at the degrader wheel, and the proton beam will
be stopped there for no more than 0.5 h/day. Average current incident on the
beamstop should not exceed 50 nA, and the shielding should be adequate to
allow a 300 nA beam to be stopped at the degrader for up to 15 min/week.
(2) The second beam stop is located downstream of the beam profile monitor after
the collimator. The beam will be stopped at this point for no more than 5
h/week, and the current should not exceed 10 nA.
(3) The third beamstop is the set of beamstops located at the entrances to the
gantry rooms. The beam stopped at these locations should not exceed 4x10' 2
protons at 235 MeV in any hour and shall not exceed 5x10 12 protons at 235
MeV per 40 h of operation.
3.2.2.2 Clinical Beam Loss
During clinical operation in the gantry treatment rooms, the large fraction of the
total beam current will be delivered to the patient. Averaged over 40 hours of operation,
these proton losses are assumed to be 1.34x1012 protons/h at 150 MeV, 3.32x10 2
protons/h at 200 MeV, and 1.87x10 12 protons/h at 235 MeV.28
3.2.2.3 Occupancy Factors
The ambient dose equivalent levels can be modified by "occupancy factors" that
take into account the amount of time the irradiated areas are occupied by workers or
members of the general public. The following are the recommendations of the NPTC
Radiation Safety Committee:28
(1) All normal contiguous interior work areas, including patient waiting areas,
shall be assigned an occupancy factor of 1.
(2) Areas such as emergency access or repair areas may be assigned an occupancy
factor of .
(3) Exterior areas that are used ony for pedestrian or vehicular traffic may be
assigned a factor of 1/16.
(4) The barrier shielding the parking lot should be assigned a factor of 4 provided
that there is no attendant on duty. If the lot is attended, that factor must be 1.
(5) Areas can be interlocked to exclude occupancy during periods of machine
operation. These areas can be assigned an occupancy factor of 0.
3.2.3 Dose Limits
The following are the dose limits used in the design of the NPTC:
(1) The maximum weekly occupational dose shall not exceed 10 mrem.
(2) The maximum weekly dose to a member of the public shall not exceed 2
mrem, subject to occupancy factors.
(3) The maximum weekly occupational dose to the extremities shall not exceed 1
rem.
(4) The dose in unrestricted areas shall not exceed 2 mrem in any single hour,
given the worst case radiation level produced.
(5) The maximum yearly total effective dose equivalent shall not exceed 100
mrem.
The MGH safety committee specified that the radiation protection program at
NPTC is to satisfy the regulations of the Commonwealth of Massachusetts, the Nuclear
Regulatory Commission, the Environmental Protection Agency, and shall satisfy the
additional requirements set forth by MGH in reference (37). While state regulations have
precedence over federal in terms of local radiation protection dose limits, Massachusetts
became an agreement state in 1997, in effect making the federal regulations and the
regulations of the Commonwealth inclusive." The dose limits above represent the most
restrictive combination of this set of regulations.
3.3 Neutron Attenuation
Neutrons are stopped in shielding through a two-step process. The first step is
moderation, in which the neutron energy is reduced through scattering reactions. The
second step is absorption, where the neutron is taken up by a nucleus and removed
entirely. The neutrons produced by the interaction of the proton beam with materials in
the beam path propagate from the beam stop and into the shielding walls. Those neutrons
that escape from the shielding are the neutrons that contribute to the dose equivalent that
the workers and general public may receive. The degree to which the initial intensity of
the neutron field is reduced is termed the attenuation of the neutron field. Neutrons lose
energy and are absorbed as they propagate through the shielding structure through
inelastic and elastic collisions with nuclei in the wall. Above 10 MeV, inelastic collisions
and non-elastic reactions tend to dominate the energy loss mechanism, while for neutron
energies ranging from a few eV to a few MeV, elastic collisions tend to dominate. In the
thermal energy range (En < .025 eV) neutrons are removed through the process of neutron
capture. 31
The cross section for inelastic collisions of high energy neutrons with nuclei
increases with the atomic number of the nuclei. For energies up to approximately 20
MeV, the inelastic cross section (oi) varies roughly as the quasi-physical cross section of
the nucleus, o, - A2/3. As the neutron energy increases, this cross section tends to
decrease. This is because the nucleus, from the standpoint of the incident neutron, looks
less and less like a solid aggregate and more like a collection of individual nucleons. The
nucleus becomes "transparent," allowing high energy neutrons a greater probability of
passing through without interaction. This cross-sectional falloff is more rapid for light
nuclei such as silicon than for heavier nuclei such as iron. On the other hand, low-Z
materials such as hydrogen will attenuate neutrons very rapidly because the neutrons tend
to lose more of their energy on average in a single collision. The average logarithmic
energy loss 4 in a single scattering is:




and A is the mass of the recoil nucleus. Thus, a fast neutron field is most readily
moderated by a combination of relatively high-Z materials and materials with large
hydrogen content.31 Once these neutrons have been moderated to thermal energies, they
can be absorbed through neutron capture in the nuclei that make up the shielding.
Concrete provides this combination relatively inexpensively, and due to its
mechanical characteristics it has the added benefit of being a viable structural material.
While shields consisting of layers of iron and lead or mixtures of concrete and
polyethylene may provide more attenuation of neutrons per unit thickness than concrete
shielding alone, they have significantly higher material and fabrication costs, and tend to
be mechanically unsound without additional support structures.7
Using the Moyer model for dose equivalent (Equation 3.3) as a function of beam
current I, the beam loss scenario described in Section 3.2.2, and the maximum allowed
dose equivalent in the environments adjacent to the accelerator and treatment rooms
described in Section 3.2.3, the following expression (Equation 3.4) can be derived for the
estimation of the shield thickness x(O) in meters with 0 being the secondary particle
(neutrons in this case) polar angle with respect to the proton beam direction:
Houtside H()inside2 * Ploss ex()m(0) (3.3)
r
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where p(O) is the mean attenuation coefficient of neutrons in the shield material in the
direction 0 with units m' (see Table 3.3), Hmax is the maximum allowed dose
equivalent rate behind the shield (2 mrem/h in this case), r is the distance between the
source and the point of interest in m, H(0) is the source term in mrem/h along the














Table 3.3. Attenuation factors used for Bechtel shielding concrete.7
3.4 Summary
In this section, the requirements for neutron shielding were discussed. The
characteristics of the Northeast Proton Therapy Center have been described, and the
general specifications for the neutron shielding in terms of the neutron sources, dose
equivalent limits, and factors that influence the choice of shielding material were
explained. In Section 4, a means by which several of these factors can be integrated into















SECTION 4 - COMPUTATIONAL SOLUTIONS
Much of the previous work in neutron shielding has utilized analytical
models,1,2,9, 2 8,30 based on approximations that may introduce significant uncertainties,
including the restriction to a one-dimensional geometry, the assumption that all
secondary particle production is in the forward direction, and the assumption that particle
production is represented by rather simple analytic expressions. These approximations
introduce uncertainty into the predicted shielding barrier thicknesses.
4.1 Monte Carlo Approach
Monte Carlo methods for solving difficult stochastic problems have been used in
some form or another for decades, following the formulation of Monte Carlo theory by
von Neumann in 1947.33 In using a Monte Carlo approach to the solution of the radiation
transport equations, the problem is formulated as a succession of individual processes
rather than in terms of macroscopic quantities. The particles to be simulated, usually
referred to as a particle history or as a 'cascade,' are transported by constructing a
mathematical 'experiment.' Particle histories comprise the trajectory of the particle,
including interaction events, e.g., elastic or Coulomb scattering events, or inelastic
nuclear events. A history terminates when the particle leaves the domain of the
geometric model, when its energy drops below a certain threshold level, or when it is
absorbed. The interaction processes and particle productions are selected at random from
a probability distribution which is either expressed in the form of theoretical or empirical
equations or represented by experimental data in tabular form."11, 41 Figure 4.1 illustrates
the random history of a neutron incident on a slab of material that can undergo an
evaporative and intranuclear cascade process. In this example, the incident neutron enters
and undergoes a scattering event at point 1. The scattered neutron travels to point 2,
where it undergoes an intranuclear cascade reaction, resulting in the scattering of the
initial neutron and the ejection of a second neutron. The first neutron escapes at point 4a.
The second neutron travels to point 3, where it undergoes a capture process, resulting in
evaporation of two neutrons. The first escapes at point 4b, the second is captured at point
5.
4b
Figure 4.1. Monte Carlo simulation of a neutron incident on a slab of material.
At any point in the cascade simulation, any required macroscopic physical quantity, such
as particle fluence, energy fluence, absorbed dose, and/or density of inelastic interactions
may be 'scored'. To 'score' these quantities means that the individual contribution to the
required physical quantity from the particle being followed may be computed and stored.
When a statistically significant number of particles (i.e., within the desired statistical
significance for the specified tally regions) have been scored, the calculated values of the
designated physical quantities may be evaluated to the required statistical accuracy
(usually < 5%).
In principle, none of the limitations of the analytical solutions listed above apply
to the Monte Carlo method. In particular, any three-dimensional geometrical
configuration containing many different media may be considered. The main
disadvantage of the Monte Carlo method is that the simulation of realistic shielding
problems with good statistical accuracy requires considerable computer resources.
4.2 Transport Codes
4.2.1 Historical Summary of LAHET and its Precursors
Event Probability Event Type
0.20 (1) Neutron Scatter
0.30 (2) Intranuclear Cascade
0.10 (3) Neutron Absorption
with Evaporation
0.35 (4) Neutron Leakage
0.05 (5) Neutron Capture
The first fully developed multi-purpose Monte Carlo charged particle transport
code to become generally available was the High Energy Transport Code (HETC).5 5
HETC allows for the simulated transport of nucleons, pions, and muons, and was
originally developed by the Neutron Physics Group at Oak Ridge National Laboratory. 46
It has for many years been a benchmark for heavy charged particle cascade codes used in
radiation physics and radiation protection.
The main feature of HETC is its incorporation of an intranuclear cascade plus
evaporation model to determine the products (along with their energies, angular
distributions, and multiplicities) from non-elastic collisions. The earliest version of the
code was developed by Coleman"s and was then known as the NMTC code. It was
limited to the calculation of cascades induced by protons of energies less than 3 GeV.
The kinetic properties of the nuclear collision products were obtained by employing the
intranuclear cascade code developed by Bertini.4'5 Below 25 MeV, charged particle
interactions were neglected and neutrons were transported using the 05R Monte Carlo
program.27 The code has undergone many revisions since then, with Bertini's earlier
intranuclear cascade code replaced by his newer MECC-7 code6 and the evaporation
portion replaced by Guthrie's EVAP-4 code. 8
As an alternative to the Bertini intranuclear cascade model, the Los Alamos High
Energy Transport code (LAHET) contains the intranuclear cascade routines from the
ISABEL code. The ISABEL intranuclear cascade model is an extension developed by
Yariv and Fraenkel6 2 of the VEGAS code. 12 It has the capability of treating nucleus-
nucleus interactions as well as particle-nucleus interactions. It allows for interactions
between particles, both of which are excited above the Fermi sea.63 The nuclear density is
represented by up to 16 density steps, rather than three as in the Bertini intranuclear
cascade model. It also allows antiproton annihilation, 13 with emission of kaons and pions.
As presently implemented in LAHET, only projectiles with A < 4 are allowed, and
antiproton annihilation is not presently allowed in particle transport problems.
Subsequent de-excitation of the residual nucleus may optionally employ a multi-
stage pre-equilibrium exciton model.42 The multi-stage pre-equilibrium model is invoked
at the completion of each intranuclear cascade, with an initial particle-hole configuration
and excitation energy determined by the outcome of the cascade. At each stage of the
multi-stage pre-equilibrium model, the excited nucleus may emit a neutron, proton,
deuteron, triton, 3He, or alpha particle or the nuclear configuration may evolve toward an
equilibrium exciton number by increasing the exciton number by one particle-hole pair.
When the multi-stage pre-equilibrium model reaches the equilibrium exciton number, it
terminates. The evaporation model or Fermi breakup model is then applied to the
residual nucleus with the remaining excitation energy."
In LAHET, the Fermi breakup model8 has replaced the evaporation model for the
disintegration of light nuclei. It treats the de-excitation process as a sequence of
simultaneous breakups of the excited nucleus into two or more products, each of which
may be a stable or unstable nucleus or a nucleon. Any unstable product nucleus is subject
to subsequent breakup. The probability for a given breakup channel is primarily
determined from the available phase space, with probabilities for two-body channels
modified by Coulomb barrier, angular momentum, and isospin factors. The model is
applied only for residual nuclei with A < 17, replacing the evaporation model for these
nuclei. In the LAHET implementation, only two- or three-body breakup channels are
considered, which is an abbreviated form of a more extensive implementation of the
Fermi breakup model.g
LAHET differs from HETC in the use of cutoff energies for particles escaping
from the nucleus during the intranuclear cascade. For either intranuclear cascade model,
the neutron cutoff energy is uniformly distributed between zero and twice the mean
binding energy. The Coulomb barrier is randomly distributed in a form simulating a
Coulomb barrier transmission probability; the maximum of the Coulomb barrier and a
neutron cutoff is then used as the proton cutoff. The sampling for the cutoff energies is
performed once for each projectile-target interaction; the barriers thus defined are then
applied to every particle emission in the resulting cascade. This procedure has the effect
of preventing a discontinuity in the particle emission spectrum while preserving the mean
particle emission rates. 45
Another small addition to the intranuclear cascade procedure that is particularly
important to the neutron shielding calculations to be performed in this work is applied to
(p,n) and (n,p) intranuclear cascade reactions only. In this case, the outgoing particle
energy is corrected by the binding energy difference in the entrance and exit channels.
The modification greatly improves the realism in the high energy emission spectrum and
significantly improves the overall energy balance in the intranuclear cascade reaction. 45
4.2.2 LAHET Code System Organization
The LAHET Code System (LCS) is a set of codes based on LAHET for the
transport and interactions of nucleons, pions, muons, light ions, and antinucleons in a
complex geometry.43 It has been extensively benchmarked, with calculations compared
against experimental results for energies up to 256 MeV, which more than covers the
energy ranges of clinical interest at NPTC. 44,45 For the purposes of this work, an updated
version of LAHET46 has been used, along with the addition of a post-processing code
(PROCESS). The linking is shown below in Figure 4.2.
Figure 4.2. Program linkage used by the LCS for the purposes of this work.
Particle tracking uses the combinatorial geometry model from the MCNP code."
LAHET shares the geometry description and input of MCNP, except for some of the finer
points, such as lattices and repeated structures, which are absent in LAHET. Charged
particle transport uses continuous slowing-down interaction models that optionally
incorporate range-straggling and multiple scattering adapted to MCNP geometry. In
addition, a LAHET history file (HISTP) may be used to generate a surface source for a
subsequent LAHET calculation.45
In LAHET, neutrons with energies below 20 MeV are written to a source file for
transport with MCNP version 4b. MCNP v.4b accepts external neutron/photon sources
created by LAHET through the use of the TRANSM code.4 6 TRANSM accepts the low-
energy surface crossing records (NEUTP for neutrons and GAMTP for photons) and
writes them to a surface-source read file (RSSA). Neutron transport from 20 MeV to
thermal energies and all photon/electron transport is then performed by MCNP v.4b,
using this source file. It may also be used for coupled neutron/photon/proton multigroup
calculations with a limited number of isotopes at energies below 100 MeV. The output
from MCNP v.4b is written to a surface-source write file (WSSA) across a set of user-
defined surfaces. MCNP v.4b can also perform edits on the surface crossing records,
including tallies of surface current and surface flux, a track length estimate of fluence and
energy deposition, and the deposition of charge. This information is then written to an
MCNP v.4b output file (OUTP).
Editing of the LAHET history file is accomplished with HTAPE, a general-
purpose particle history editor. Edits include surface current, surface flux, neutron
volume flux, particle production spectra, energy deposition and balance, distribution of
residual nuclei and excitation, gas production, and pulse shape characteristics.43 HTAPE
combines the output from the high-energy (above 20 MeV) neutron surface-crossing
histories (HISTP) with the MCNP v.4b output (WSSA) to evaluate the above quantities.
Unfortunately, due to the fact that HTAPE can only read in surface crossing records from
the WSSA file, the only edits that it can perform that are applicable to the determination
of neutron dose equivalent are the surface current and surface flux edits. In order to
perform tallies such as energy deposition or track length estimate of flux, a separate
program (PROCESS) must be invoked that can read the tallied information from the
MCNP v.4b OUTP file and included in the higher energy neutron edits performed by the
HTAPE program. This user supplied program will be discussed in greater detail in
Section 5.5.
SECTION 5 - THE MONTE CARLO STUDY
5.1 Modeling Considerations
For studying the neutron shielding problem, the system of codes (LCS) described
in section 4.2.2 has been implemented. A Hewlett-Packard workstation running HP
UNIX v.10.20 was configured as the platform on which to run the various programs. The
considerations that must be dealt with in developing a Monte Carlo model for this
shielding situation are 1) the development of a geometry that realistically reflects the
shielding design used in the proton therapy facility, 2) the determination of the neutron
source terms, 3) the characterization of the materials present in the problem, 4) the
development of methods to handle the massive influx of data generated in the course of
the LAHET calculation and subsequent editing, and 5) determining how best to interpret
the data generated.
5.2 Shielding Geometry
The geometry was modeled using the as-built shielding designs provided by
Bechtel Corporation (Figure 5.1).7 These designs accurately portray the bulk shielding of
the Northeast Proton Therapy Center, but omit some modifications made to the shielding
during construction, such as the inclusion of ducts and other conduits through the
shielding wall.
The NPTC shielding geometry model, comprising over 200 contiguous cells
composed of approximately 150 unique surfaces, is shown below in Figures 5.2 and 5.3
with the aid of the 2-dimensional MCPLOT function provided with the MCNP4b
package" and the 3-dimensional SABRINA visualization package, 59 as shown in Figure
5.4. Software detectors (tally regions) have been distributed throughout the NPTC
facility, including one at each of the calculation locations chosen by Larson et al.28 in
their shielding study. The locations of the tally regions on the treatment level are
depicted as small spheres in Figure 5.2.
Figure 5.1. As-built drawing of the treatment level shielding.7
Figure 5.2. 2-dimensional plan view of NPTC treatment level. The software
detectors are shown as small circles.
Figure 53. 2-dimensional side view of NPTC, cut through Gantry Bay 1. The software
detectors are shown as small circles.
Figure 5.4. 3-dimensional view of NPTC bulk shielding.
5.3 Source Terms
Our preliminary shielding simulations include only one neutron source, which
comprises an isotropic proton source located within a 10-cm sphere of copper. The
geometry of an isotropic source within the beamstop was chosen because the version
LAHET available for this study does not currently allow for a parallel beam source with
arbitrary initial direction. Moreover, unlike MCNP v.4b, LAHET does not allow for
transformation of the geometry coordinates with a transformation card.'11, 43 While the use
of an isotropic source is not entirely realistic, it provides an adequate source for testing
and code development work. Modifications are being made to the LCS to allow for full
directional biasing of the source. The spectral fluences for neutron sources comprising a
10-cm copper sphere (beam stop) and a 15-cm tissue equivalent sphere (patient) were
then computed for incident proton energies of 150, 200, and 235 MeV, the clinical loss
energies described in Section 3.2.2.2. The emission spectra at the surfaces of these







IL, * o v cuNeutron oE o
LU L Lu IU





O O Oo> V- (N
+ + +(NJ W W
Nu NU NUt~q ¢,q ¢,
Figure 5.5. Neutron spectral fluence for neutrons produced by a 150 MeV isotropic proton source in a 10
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Figure 5.6. Neutron spectral fluence for neutrons produced by a 200 MeV isotropic proton source in a 10
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Figure 5.7. Neutron spectral fluence for neutrons produced by a 235 MeV isotropic proton source in a 10
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Figure 5.8. Neutron spectral fluence for neutrons produced by a 150 MeV isotropic proton source in a 15
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Figure 5.9. Neutron spectral fluence for neutrons produced by a 200 MeV isotropic proton source in a 15
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Figure 5.10. Neutron spectral fluence for neutrons produced by a 235 MeV isotropic proton source in a 15
cm sphere of A-150 tissue equivalent plastic.
This approximation of the source term provides a full energy range of neutrons to
transport using LAHET and MCNP4b.
5.4 Shielding Material
The discussion of materials appropriate for the shielding of fast neutrons is
covered in Section 3.3. The shielding concrete used by Bechtel is composed primarily of
hydrogen, carbon, oxygen, magnesium, silicon, and calcium, presenting a wide variety of
light nuclei for neutron moderation and heavier nuclei for neutron absorption. The proton
and neutron elastic scattering cross-section data libraries available for LAHET are not
complete for all elements. Therefore, for elements that do not have elastic cross-sections
for use in LAHET, the proton and neutron elastic scattering cross-sections of heavier
elements were substituted. For example, there is no elastic scattering cross-sectional
information presently available for calcium or magnesium, two constituents of the NPTC
shielding concrete, available in LAHET. To overcome this deficiency elements with
larger mass numbers, such as titanium and aluminum, can be used instead. This is
actually conservative because elements with larger mass number A have lower
moderating properties, an assertion that is supported in 64) and can also be quantitatively
defended by means of the average logarithmic energy loss 4 in a single scattering, as
described by equations 3.1 and 3.2 in Section 3.3. This works out to an 4 of 0.0492 for
Ca, 0.0411 for Ti, 0.0811 for Mg, and 0.0723 for Al. The mass fractions and nuclear
densities of NPTC shielding concrete and of air are included in the Appendix.
5.5 Data Processing and Analysis
Modeling this problem in the fullest possible detail is a formidable problem in
terms of organization and data handling. The calculation the neutron dose equivalent
values requires the combination of neutron source terms arising from approximately 63
discrete proton-induced neutron sources at several proton beam energies ranging from 70
to 235 MeV, with protons incident on several beam stop materials (e.g., graphite, tissue-
equivalent plastic, copper, iron). The shielding performance from these sources is then to
be calculated at roughly 50 locations to determine the average neutron dose equivalent
and peak neutron dose equivalent rate. To minimize the time needed to model each of
these possible sources individually and to handle the massive amounts of information
generated, computer programs been written for the automated creation of LAHET input
files and for post processing of the LAHET output files.36
A simulation with the LAHET code requires enormous amounts of disk space.
This is because LAHET writes a detailed interaction history for each particle transported.
For example, to simulate the transport of 100,000 protons through the geometry
developed for the NPTC results in over 100 Mbytes of data. To run a simulation that is
capable of attaining statistics acceptable for a scientific study would require the transport
of tens or even hundreds of millions of particles. This would require terabytes of disk
storage space, which is simply beyond our present day resources. To deal with this
situation, a program that allows the user to combine the selected output data from a large
number of smaller runs into a single file has been written and is in the process of being
tested.
The LAHET code does not predict the neutron dose equivalent values directly.
Like MCNP, an edit program (HTAPE) reads in the surface crossing and interaction data
from the history files and recovers the information pertinent to the type of tally being
performed. Due to the edit limitations discussed in Section 4.2.2., HTAPE editing is
limited to those edits that are derived from surface crossing records, such as neutron
surface flux or surface current. The quantities provided by HTAPE are in neutron fluence
(neutrons/cm2) per incident neutron. This value can be multiplied by the ratio of the
number of neutrons created in the simulation to the number of protons simulated to obtain
the neutron spectral fluence per incident proton. Energy dependent fluence-to-dose
equivalent conversion coefficients are available from the literature, and provide one way
by which the predicted neutron spectral fluences can be converted into a neutron dose
equivalent values. 20' 35'58 (Figure 5.3, also Section 2.3) The post-processing code discussed
in Section 5.5 is currently undergoing modification to allow the > 20 MeV edits
performed by HTAPE to be merged with the < 20 MeV edits performed by MCNP,
bypassing the surface crossing restriction entirely and allowing for the full range of tallies
to be utilized.
Neutron Energy NCRP-3835 Fluence-to-Dose Equivalent ICRP-2120 Fluence-to-Dose Equivalent




















Table 5.3. Neutron fluence-to-dose equivalent rate conversion coefficients.
5.6 Uncertainties
The major difficulty presented in the use of Monte Carlo methods in systems that
comprise large geometries and a high degree of attenuation is that very few particles
actually reach the points where tallies are being performed. This creates a high degree of
uncertainty in the calculations unless a large number of particles can be run. The
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and N is the total number of particle histories. However,
x2X and S = x2(x)21 NN E=Xi2
combining,
(5.6)




so let n i = the number of nonzero scores per run that are equal to x, n i << N, so
(5.8)nix 1
ni2X2 -
for n i << N, where R i is the relative uncertainty calculated per run.
Thus, in order to calculate the total uncertainty for a group of dependent
calculations, the post-processing code takes the relative uncertainty calculated per run R i






The total number of nonzero scores for all dependent calculations is then determined by
summing the nonzero scores ni for each run,
n = ni  (5.10)
for I dependent runs.
The total relative uncertainty is then
1
R ; nn  (5.11)
which follows the general format for relative uncertainty used in LAHET and MCNP and
allows us to track the precision of our measurements, until enough histories have been
run that our results are statistically significant.
5.7 Summary
In this section, the foundation for a comprehensive method of performing Monte-
Carlo based proton-induced neutron shielding calculations in a complex geometry has
been lain. The bulk shielding structure has been successfully modeled, and software tools
to read and interpret the data that the LCS provides have been developed. Preliminary
testing of the tools developed in this work, including the geometry model in Section 5.2,
the source term definition in Section 5.3, the materials model presented in Section 5.4,
and the data interpretation techniques discussed in Section 5.5 suggest that the these tools
are working properly. A comparison of predicted and measured values is presented in the
following section. While a large amount of software development work and simulation
time remain before the multiple source predictions of the shielding performance will be
available, many of the obstacles to solving this shielding problem have been overcome.
The next section will discuss a means by which the LAHET neutron dose equivalent
predictions can be verified.
SECTION 6 - VERIFICATION OF CALCULATIONS
6.1 Verification of LAHET Predictions
While the LCS has been extensively and repeatedly benchmarked 44' 4 5 at LANL
and in other shielding studies, 50 calculations in a geometry of the complexity of the
Northeast Proton Therapy Center have not been attempted. The LAHET simulations
proposed by this work can be verified experimentally, under the same operating
conditions assumed in determining the calculated values. Measurements of neutron dose
equivalent rate, along with a knowledge of the beam loss configuration (i.e., the neutron
source terms) are needed for this verification of the shielding performance.
The measurements may also reveal hidden flaws in the predictions, as the models
may not include all of the relevant geometrical features, such as the inclusion of conduits,
or of conditions that do not conform to those assumed in the construction, such as cracks
or changes in the concrete density due to the absorption of water. Finally, long-term
monitoring with the above measurement systems provides dose equivalent values that are
based on the actual clinical workload, as opposed to the workload that was estimated for
the shielding design.7'37 Much of the data processing software for this task has already
been developed at MGH and tested during the period of routine radiation protection
measurements that have been performed to verify compliance with the dose restriction set
by MGH and NPTC.
6.1.1 Neutron Detection Apparatus
Since the June of 1997 startup of the cyclotron at NPTC, the neutron dose
equivalent rates at several locations have been monitored with a combination of thermo-
luminescent dosimeters (TLD) and with up to six active neutron dose equivalent meters.
The TLD's are passive dosimeters which are deployed for a period of 3 to 6 months. The
latter type of dosimeter comprises a boron trifluoride (BF 3) proportional counter, a
polyethylene moderating sphere, a pulse-height discriminator and scalar, (Ludlum
Measurements, Inc., Detector Model 42-31, Electronics Model 2241, Sweetwater, TX)
and a personal-computer-based data acquisition system.
The boron trifluoride (BF 3) proportional counters are of a simplified Andersson-
Braun (AB) type.3 The detection mechanism of the AB counter is based on the nuclear
properties of the BF 3 that fills the proportional chamber. One of the isotopes of boron,
oB, has a very high thermal neutron capture cross section (3840 barns). By housing the
detector within a polyethylene shell, the neutron field can be moderated, or slowed down,
to thermal energies. In the loB(n,c)'Li reaction,(Q value=2.4 MeV, Ea=1.47 MeV) a
thermal neutron is captured by the 'oB nucleus, resulting in the formation of an excited
compound nucleus. This nucleus then de-excitates by the emission of an ca particle,
which also carries off most of the excited nucleus' energy. The deposition of the (n,a)
reaction products' energy in the proportional gas registers as an electrical pulse. If that
pulse is above a fixed pulse height discriminator level, it registers as a count. These
counts are converted to the dose equivalent with a calibration coefficient. The associated
electronics comprise a single channel analyzer for pulse height analysis, a
microprocessor-controlled scalar/ratemeter/timer, and a high voltage power supply
(HVPS). The meter sends the count rate to a PC via an RS-232 serial communication
port. The meters have been retrofitted with bulkhead DB-9 connectors for the serial port
and 3-conductor jacks. Provisions for an external 3-V power supply were added to
reduce reliance on the internal battery power.
Data acquisition and online display are performed by a program written in
BASIC, running on a personal computer (386 laptops, one per meter). The
scalar/ratemeter transmits a stream of data to a computer and includes the count rate,
scalar count, count time, and preset count time remaining. The logging program then
reads and stores selected information from the stream. At 1-min intervals, a record is
written to the hard disk comprising the time of day, the total scalar counts during that 1-
min interval, and the scalar counts during each 2-s subinterval of that minute. Scored
over time, these counts can be converted to a dose-equivalent rate by an appropriate
calibration coefficient. This calibration coefficient is determined by irradiating the meter
in a known neutron calibration field.
A 5 + 0.5 Ci (95% confidence interval) Am-Be (24 1Am: T 1/2 = 433 y) neutron
source (Amersham Corp., 5-Ci OWL Neutron Source, Model AMN.CY5, Serial No.
6829NE, Arlington Heights, IL) has been obtained to supply the calibration field. This
Am-Be source provides a dose equivalent rate H(r0) of 11.0 + 1.1 (95% confidence
interval) mrem/min/Ci at a distance r0 of 1 m, based on a mean quality factor of 10. The






Where H is the neutron dose equivalent rate at the meter and N is the count rate
registered by the meter. Experimentally, this becomes
0
S H(ro)(r/ro) (6.2)c= o (6.2)
Nnet(r)
0
H(ro)(r/ro) (6.3)C o o (6.3)
(Ntot(r)-Nbkg)
0
where r is the distance from the source to the detector. Nnet(r)is the net count rate at
distance r, which is equal to the total count rate, Ntot(r)minus the average background
0
count rate, Nbkg.
6.1.2 Neutron Dose Equivalent Measurements
Much of the NPTC beam delivery system and beam line instrumentation has yet
to be completely installed, which means that the beam intensity, beam loss locations, and
other factors that influence the neutron source terms are not yet available. While these
data are needed for a proper shielding study, preliminary measurements have been made
in order to ensure compliance with radiation protection regulations. An example plot of
the measured data used for radiation protection purposes is given in Figure 6.1. The
neutron dose equivalent rate inside the accelerator vault can be multiplied by a
conversion factor that incorporates a ratio between the dose equivalent rate inside the
vault and the neutron dose equivalent rate on the driveway behind NPTC to constantly
monitor the neutron dose equivalent in unrestricted areas, i.e., the neutron dose equivalent
potentially received by members of the general public. In this case, the measurements
were performed because huge gaps existed in the shielding during the construction phase,
concurrent with accelerator and beamline development. This information has been used
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Figure 6.1. Neutron dose equivalent rates measured at several locations in the NPTC.
6.1.3 Comparison of Measurements and Calculations
Use of the neutron dose equivalent meters for radiation protection purposes has
provided valuable experience not only with the detection equipment, but with the data
acquisition system and post-measurement data analysis. Experimental measurements of
this type are representative of the neutron dose equivalent measurements that will be
physically produced during beam operation, and will be compared to the neutron dose
equivalent rates predicted by the LAHET simulations. An example of this application is
shown in Figure 6.2, which plots the measured neutron dose equivalent rate at several
positions on the treatment floor during a period where a 10 nA (6x1010 protons/sec) 235
MeV proton beam was deposited fully in a copper beamstop located at the isocenter of
Gantry Bay 1, the first of the two primary treatment rooms. The locations of the neutron
dose equivalent meters placed inside the vault, Control Room 2, and the Patient
Debriefing Area are shown in Figure 6.3.
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Figure 6.2. Comparison of neutron dose equivalent >rates measured in NPTC at various locations.
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Figure 6.3. Locations of neutron dose equivalent monitoring equipment during experiment.
A summary of the measured dose rates during
and the calculated dose rates for a 10 nA 235 MeV
beamstop (see Section 5.3) is shown in Table 6.1.
a 10 minute data acquisition period
proton beam incident on a copper
Treatment Floor Measured Dose Equivalent Rate Calculated Dose Equivalent Rate
Position (mrem/h) (mrem/h)
Outside Gantry Bay
1 Door, Hallway 0.073 0.064
Control Room 2 0.012 0.012
Inside Vault, near
Gantry Bay 2 Pit 0.34 0.070
Table 6.1. Comparison of measured and calculated neutron dose equivalent rate values.
The values shown in Table 6.1 demonstrate that the values for neutron dose equivalent
predicted by LAHET using the shielding geometry developed in this work agree
relatively well with measured values, except for that of the accelerator vault, near the
Gantry Bay 2 pit. One possible reason for this relatively large difference in predicted and
measured values for the neutron dose equivalent rate is that points within the vault are
relatively unshielded from neutrons produced in the accelerator housing and the beam
line equipment, while the hallway and control rooms are very heavily shielded with
respect to these source terms. As the only source term simulated in this preliminary study
was the copper beam stop inside Gantry Bay 1, the vault values will be underpredicted
while the hallway and control room 2 values will be reasonably close to the measured
values. The relative uncertainties associated with these predicted values are all under
30%, which, according to the guidelines used for interpreting relative uncertainty
presented by the Transport Methods Group of the Applied Theoretical and Computational
Physics Division at the Los Alamos National Laboratories, can be considered reliable
within a factor of two or three." This relative uncertainty can be expected to improve as
the number of particles simulated increases.
6.1.4 Shielding Verification
The verification of the NPTC neutron shielding using the detector and data
acquisition apparatus described above is a vital task in the licensing of the facility. Using
the original NPTC shielding design by Larson et al.,28 the Bechtel Corporation calculated
the neutron dose equivalent at 25 locations on the treatment floor, which are indicated by
the circles in Figure 5.2 in the previous section. Those locations where personnel may
face exposure to neutron radiation will be observed using the neutron dose equivalent
detection and monitoring equipment described in Section 6.1.1.
One of the most important variables in the shielding verification study is where
the neutrons will be produced. In the case of NPTC, this will consist of a minimum of 63
source terms, comprising 3 incident proton energies (150, 200, and 235 MeV), 3 incident
proton intensities (10, 50, and 300 nA), 4 beam stop materials (graphite, iron, copper, and
tissue), and a set of material-dependent beam stop locations, e.g., degrader wheel (copper
and graphite), beam profile monitor (copper), 2 gantry bay entrances (copper), and 2
patients (tissue). An almost infinite number of source terms could be considered to arise
from locations in the bending and focusing magnets, but these are chronic losses that
cannot be rigidly controlled
Once the beamline monitoring instrumentation is fully operational, information on
the proton beam characteristics will be constantly available. For a limited subset of beam
operating conditions, including but not limited to beam stop location, beam stop
composition, proton beam current, and incident proton energy, measurements will be
made at each of the specified locations above of the neutron dose equivalent experienced
at that location. In this way it can be determined if the shielding is adequate to meet the
radiological safety requirements of the workers and the general public, in accordance to
the limits stated in Section 3.2.3. Once a suitable set of measurements have been
performed, a bank of experimental data will then be available that can be compared to
each neutron dose equivalent rate calculated by LAHET for the specified tally regions.
This allows for the comparison of experimental and computational results and the
verification of the simulation.
6.2 Summary
A system for verifying the LAHET neutron shielding calculations while
simultaneously providing an experimental means of verifying that the neutron shielding
for NPTC meets the dose limits during clinical operating conditions has been provided.
Six data acquisition systems have been assembled and modified in order to monitor the
neutron dose equivalent during proton beam operation at several locations on a
continuous basis.
SECTION 7 - CONCLUSIONS AND FUTURE WORK
7.1 Conclusions
The goal of this work was to develop improved tools for shielding calculations
through the application of Monte Carlo methods in a complex, realistic geometry. In
meeting this goal, the bulk shielding structure was modeled, and software tools to read
and interpret the data that the LCS provides were developed. The tools developed in this
work include a geometry model, a source term definition, a materials specification, and
data interpretation techniques. A comparison of preliminary calculations with
measurements suggests that these tools are working properly and the simulation model is
valid. Neutron detection and data acquisition systems have been assembled in order to
monitor the neutron dose equivalent during proton beam operation at several locations on
a continuous basis, and a study implementing these data acquisition systems for verifying
the LAHET neutron shielding calculations while simultaneously providing an
experimental means of verifying that the neutron shielding for NPTC meets the dose
limits during clinical operating conditions has been provided.
7.2 Future Work
Following the completion of the full simulation and experimental verification of
the results for the Northeast Proton Therapy Center, several applications of the Monte
Carlo model and the software tools developed in this work may prove viable. One such
possibility would be modifications to the NPTC shielding, possibly in the form of
addressing adjusted shielding requirements for increased operating capacity, or
developing an optimization study of the neutron shielding for future proton therapy
facilities.
7.2.1 Shielding Remediation and Modifications
If modifications need to be made to the NPTC shielding, such as the drilling of a
new conduit for the purpose of running power or signal cable to a point within the
shielding vault, the computer simulation shall provide us with a means by which to test
such unplanned changes to the shielding before they are made. This testing will provide
an idea as to what the possible radiation protection consequences of introducing a flaw
into the shielding configuration might be.
If an existing shielding design proves inadequate, whether due to higher than
expected patient load or unforeseen treatment configurations, it may become necessary to
add additional shielding or to limit the clinical treatment load. If space or cost prohibit
the installation of additional shielding, some adjustment to the treatment load may
become necessary. As will be described in Section 7.2.2, one could optimize the patient
treatment configurations without making changes in the shielding design. Use of such a
simulation will also allow for the design and testing of localized shielding around
established neutron sources, which will also allow for reduction of the dose equivalent
rates outside the shielding without any further modification to the bulk shielding
structure.
The simulation tools will allow us to test alternative shielding materials in order
to reduce their cost and size. Computer simulations may also facilitate the testing of
beam line materials that optimize beam quality for treatment while minimizing this
neutron production. In the case of NPTC, the simulation could also provide for an
optimized shielding design for a third gantry treatment room. A rigorous computer aided
design may allow us to build the third treatment room with less shielding, making its
construction a more financially viable option, with the potential of increasing the clinical
capacity of the facility.
7.2.2 Shielding Optimization
In order to utilize the Monte Carlo model developed for NPTC to optimize
neutron shielding in new facilities, a system by which to iteratively determine the "best"
design must be integrated. While case-by-case improvements on specific problem areas
requires comparatively little computer time, they are inefficient in the long term in that
they are based on educated guesses. Numerical optimization algorithms may offer an
alternative approach to optimizing neutron shielding design. There are two basic means
by which to obtain the optimum shielding solution: one is to vary the barrier thickness for
some fixed set of operating conditions, the other is to vary the operating conditions for a
given set of shielding barrier thicknesses. The former is the approach to be used for
designing new facilities, and the latter may provide an economical remedial solution if
deficiencies in the shielding appear, whether due to a flaw in the original shielding design
or changes in the patient treatment load or configuration. For optimization work, the cost
variable as a function of barrier thickness will be minimized while the dose equivalent
rates are constrained to the specified dose limits where the facility is to be constructed.
Care must be taken, however, that the optimization configuration determined is a true
global optimum, rather than a local optimum that does not reflect on the shielding needs
of the entire facility.
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APPENDIX
Section 1. Isotopic abundances of materials used in the simulation.
Isotope Mass Percent Mass p p
[amu] Abundance Fraction [A3] [g/cc]
H-1 1.007825 99.985 0.100970 6.7572E-02 1.1309E-01
H-2 2.014102 0.015 0.000030 1.0000E-05 3.4000E-05
H-nat 1.007976 100 0.101000 6.7582E-02 1.1321E-01
C-12 12.000000 98.9 0.767633 4.3147E-02 8.5978E-01
C-13 13.003355 1.1 0.009337 4.8400E-04 1.0458E-02
C-nat 12.011137 100 0.777000 4.3631E-02 8.7024E-01
0-16 15.994915 99.76 0.051860 2.1868E-03 5.8083E-02
0-17 16.999131 0.038 0.000021 8.3298E-07 2.3514E-05
0-18 17.999160 0.204 0.000119 4.4718E-06 1.3366E-04
O-nat 15.999705 100 0.052000 2.1921E-03 5.8240E-02
N-14 14.003074 99.63 0.034863 1.6792E-03 3.9046E-02
N-15 15.000109 0.366 0.000137 6.1686E-06 1.5400E-04
N-nat 14.006163 100 0.035000 1.6854E-03 3.9200E-02
Table A.1. Isotopic masses, abundances, mass fractions, and densities in A-150 tissue equivalent plastic.
(p=1.127 g/cc)
Isotope Mass Percent Mass p P
[amu] Abundance Fraction [A3] [g/cc]
Cu-63 62.929599 69.2 0.685298 5.8628E-02 6.1266E+00
Cu-65 64.927793 30.8 0.314702 2.6094E-02 2.8134E+00
Cu-nat 63.545403 100 1.000000 8.4722E-02 8.9400E+00
Table A.2. Isotopic masses, abundances, mass fractions, and densities in copper. (p=8.94 g/cc)
Isotope Mass Percent Mass p p
[amu] Abundance Fraction [A 3 ] [g/cc]
C-12 12.000000 98.9 0.987983 8.4286E-02 1.6796E+00
C-13 13.003355 1.1 0.012017 9.4600E-04 2.0429E-02
C-nat 12.011137 100 1.000000 8.5233E-02 1.7000E+00
Table A.3. Isotopic masses, abundances, mass fractions, and densities in graphite. (p=1.7 g/cc)
Isotope Mass Percent Mass p p
[amu] Abundance Fraction [A3] [g/cc]
H-1 1.007825 99.985 0.000000 0.0000E+00 0.0000E+00
H-2 2.014102 0.015 0.000000 0.0000E+00 0.0000E+00
H-nat 1.007976 100 0.000000 0.0000E+00 0.0000E+00
C-12 12.000000 98.9 0.000123 7.4083E-09 1.4762E-07
C-13 13.003355 1.1 0.000001 8.3155E-11 1.7956E-09
C-nat 12.011137 100 0.000124 4.3631E-02 1.4942E-07
0-16 15.994915 99.76 0.231155 1.0487E-05 2.7854E-04
0-17 16.999131 0.038 0.000094 3.9946E-09 1.1276E-07
0-18 17.999160 0.204 0.000532 2.1445E-08 6.4097E-07
O-nat 15.999705 100 0.231781 1.0512E-05 2.7930E-04
N-14 14.003074 99.63 0.752307 3.8985E-05 9.0653E-04
N-15 15.000109 0.366 0.002960 1.4322E-07 3.5673E-06
N-nat 14.006163 100 0.755267 3.9128E-05 9.1010E-04
F-nat 18.998403 100 0.017000 6.4932E-07 2.0485E-05
Ar-36 35.967546 0.337 0.000039 7.8523E-10 4.6899E-08
Ar-38 37.962000 0.063 0.000566 1.3337E-09 8.4072E-08
Ar-40 39.962000 99.6 0.942020 2.1984E-06 1.3992E-04
O-nat 39.942000 100 0.231781 2.1106E-06 1.4005E-04
Table A.4. Isotopic masses, abundances, mass fractions, and densities in air. (p=1.23E-3 g/cc)
Isotope Mass Percent Mass p p
[amu] Abundance Fraction [A 3] [g/ce]
H-1 99.985 99.985 0.005998 1.0150E-02 1.6987E-02
H-2 0.015 0.015 0.000002 1.5227E-06 5.0929E-06
H-nat 100 100 0.006000 1.0152E-02 1.6992E-02
C-12 12.000000 98.9 0.152149 2.1623E-02 4.3089E-01
C-13 13.003355 1.1 0.001851 2.4271E-04 5.2409E-03
C-nat 12.011137 100 0.154000 2.1866E-02 4.3613E-01
0-16 15.994915 99.76 0.356037 3.7962E-02 1.0083E+00
0-17 16.999131 0.038 0.000144 1.4460E-05 4.0819E-04
0-18 17.999160 0.204 0.000819 7.7628E-05 2.3202E-03
O-nat 15.999705 100 0.357000 3.8054E-02 1.0110E+00
Mg-24 23.985042 78.99 0.021046 1.4965E-03 5.9604E-02
Mg-25 24.985837 10 0.002776 1.8945E-04 7.8606E-03
Mg-26 25.982594 11.01 0.003178 2.0859E-04 8.9997E-03
Mg-nat 24.302421 100 0.027000 1.8945E-03 7.6464E-02
Si-28 27.976927 92.23 0.172722 1.0529E-02 4.8915E-01
Si-29 28.976495 4.67 0.009058 5.3312E-04 2.5653E-02
Si-30 29.973770 3.1 0.006220 3.5389E-04 1.7615E-02
Si-nat 28.085509 100 0.188000 1.1416E-02 5.3242E-01
Ca-40 39.963591 96.94 0.259044 1.1055E-02 7.3361E-01
Ca-42 41.958618 0.647 0.001815 7.3783E-05 5.1409E-03
Ca-43 42.958766 0.135 0.000388 1.5395E-05 1.0982E-03
Ca-44 43.955481 2.09 0.006143 2.3834E-04 1.7397E-02
Ca-46 45.953689 0.0035 0.000011 3.9913E-07 3.0458E-05
Ca-48 47.952533 0.187 0.000600 2.1325E-05 1.6981E-03
Ca-nat 40.080120 100 0.268000 1.4040E-02 7.5898E-01
Table A.5. Isotopic masses, abundances, mass fractions, and densities in concrete. (p=2.832 g/cc)
